Skip to main content
SpringerLink
Log in

ATM heterozygosity and breast cancer: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Based upon the results of several epidemiologic studies, it has been suggested that women who are carriers for a mutation in the ataxia telangiectasia-mutated (ATM) gene are susceptible for the development of breast cancer. Therefore, 37 consecutive breast cancer patients were screened for the presence of a germline ATM mutation using a non-isotopic RNase cleavage-based assay (NIRCA). This paper reports the first use of NIRCA for detection of ATM mutations in breast cancer patients. Using this assay, no ATM mutations were found in our patient population. This result is similar to the findings of other studies that have employed approaches complementary to NIRCA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shiloh Y: Ataxia telangiectasia: closer to unraveling the mystery. Eur J Hum Genet 3:116–138, 1995

    PubMed  Google Scholar 

  2. Morell D, Cromartie E, Swift M: Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 77: 89–92, 1986

    PubMed  Google Scholar 

  3. Gatti RA, Berkel I, Boder E, Braedt C, Charmley P, Concannon P, Ersoy F, Foroud T, Jasper NGJ, Lange K, Lahtrop GM, Leppert M, Nakamura Y, O'Connell P, Paterson M, Salser W, Sanal O, Silver J, Sparkes RS, Susi E, Weeks DE, Wei S, White R, Yoder F: Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 336: 577–580, 1988

    PubMed  Google Scholar 

  4. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Seez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y: A single gene with a product similar to PI3-kinase and Rad 3 is mutated in ataxia telangiectasia. Science 268: 1749–1753, 1995

    PubMed  Google Scholar 

  5. Telatar M, Teraoka S, Wang Z, Chun HH, Liang T, Castellvi-Bell S, Udar N, Borresen-Dale AL, Chessa L, Bernatowska-Matuzkievicz E, Porras O, Watanabe M, Junker A, Concannon P, Gatti R: Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. Am J Hum Genet 62: 86–97,1998

    PubMed  Google Scholar 

  6. Concannon P, Gatti A: Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Hum Mutat 10: 100–107, 1997

    PubMed  Google Scholar 

  7. Gotoff SP, Amirmokri E, Liebner EJ: Ataxia-telangiectasia. Am J Dis Child 114: 617–625, 1967

    PubMed  Google Scholar 

  8. Dhand R, Hues I, Panayotou G, Roche S, Fry MJ, Gout I, Totty NF, Truong O, Vicendo P, Yonezawa K, Kasuga M, Courtneidge SA, Waterfield MD: PI3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J 13: 522–533, 1994

    PubMed  Google Scholar 

  9. Tanti JF, Gremeaux T, Wan Obberghen F, LeMarchand-Brustel Y: Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem J 304: 17–21, 1994

    PubMed  Google Scholar 

  10. Freund GG, Wittig JG, Mooney RA: The PI3-kinase serine kinase phosphorylates its p85 subunit and IRS-1 in PI3-kinase/IRS1-complexes. Biochem Biophys Res Commun 206: 272–278, 1995

    PubMed  Google Scholar 

  11. Harnden DG: The nature of ataxia-telangiectasia: problems and perspectives.Int J Radiat Biol 66: S13–S19, 1994

  12. Taylor AMR, Byrd PJ, McConville CM, Thacker S: Genetic and cellular features of ataxia-telangiectasia. Int J Radiat Biol 65: 65–70, 1994

    PubMed  Google Scholar 

  13. Swift M, Morell D, Cromartie E, Chamberlin AR, Skolnik MH, Bishop DT: The incidence and gene frequency of ataxiatelangiectasia in the United States.Am J Hum Genet 39: 573–583, 1986

    PubMed  Google Scholar 

  14. Chen PC, Lavin MF, Kidson C, Moss D: Identification of ataxia-telangiectasia heterozygotes, a cancer prone population. Nature 274: 484–486, 1978

    PubMed  Google Scholar 

  15. Weeks DE, Paterson MC, Lange K, Andrais B, Davis RC, Yoder F, Gatti RA: Assessment of chronic radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia.Radiat Res 128: 90–99, 1991

    PubMed  Google Scholar 

  16. Borresen AL, Anderson TI, Treti S, Heiberg A, Moller P: Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chrom Cancer 2: 339–340, 1990

    PubMed  Google Scholar 

  17. Swift M, Morrell D, Massey RB, Chase CL: Incidence of cancer in 161 families affected by ataxia-telangiectasia.N Engl J Med 325: 1831–1836, 1991

    PubMed  Google Scholar 

  18. Athma P, Rappaport R, Swift M: Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130–134, 1996

    PubMed  Google Scholar 

  19. Swift M, Reitnauer PJ, Morel D, Chase CL: Breast and other cancers in families with ataxia-telangiectasia.N Engl J Med 316: 1289–1294, 1987

    PubMed  Google Scholar 

  20. Easton DF: Cancer risk in ataxia-telangiectasia heterozygotes. lnt J Radiat Biol 66: S177–S182, 1994

    Google Scholar 

  21. Pippard EC, Hall AJ, Barker DJP, Bridges BA: Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain.Cancer Res 48: 2929–2932, 1988

    PubMed  Google Scholar 

  22. Vorechovsky I, Rasio D, Luo L, Monaco C, Hammarstrom L, Webster ADB, Zaloudik J, Barbanti-Brodano G, James M, Russo G, Croce CM, Negrini M: The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 56: 2726–2732, 1996

    PubMed  Google Scholar 

  23. Bay JO, Grancho M, Pernin D, Presneau N, Rio P, Tchirkov A, Uhrhammer N, Verrelle P, Gatti RA, Bignon YJ: No evidence for constitutional ATM mutation in breast/gastric cancer families.Int J Oncol 12: 1385–1390, 1998

    PubMed  Google Scholar 

  24. Chen J, Giesler-Birkholtz G, Lindblom P, Rublo C and Lindblom A: The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res 58: 1376–1379, 1998

    PubMed  Google Scholar 

  25. Appleby JM, Barber JB, Levine E, Varley JM, Taylor AM, Stankovic T, Heighway J, Warren C, Scott D: Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy.Br J Cancer 76: 1546–1549, 1997

    PubMed  Google Scholar 

  26. Clarke RA, Goozee GR, Birrell G, Fang ZM, Hasnain H, LavinM, Kearsley JH: Absence of ATMtruncations in patients with severe acute radiation reactions. Int J Radiation Oncol Biol Phys 41: 1021–1027, 1998

    Google Scholar 

  27. Ramsay J, Birrell G, Lavin M: Testing for mutations of the ataxia-telangiectasia gene in radiosensitive breast cancer patients.Radiother Oncol 47: 125–128, 1998

    PubMed  Google Scholar 

  28. Goldrick MM, Kimball GR, Liu Q, Martin LA, Sommer SS, Tseng JY-H: NIRCA: A rapid robust method for screening for unknown point mutations. BioTechniques 21: 106–112, 1996

    PubMed  Google Scholar 

  29. Watkins HC, M Goldrick: Cleavage of RNA–RNA hybrids at mutation sites using the nonisotopic RNase cleavage assay (NIRCA).In: Dracopoli NC et al. (eds) Current Protocols in Human Genetics. Wiley, New York 1998, pp 7.2.5-7.2.18.

    Google Scholar 

  30. Castellvi-Bel S, Sheikhavandi S, Telatar M, Tai L-Q, Hwang M, Wang Z, Yang Z, Cheng R, Gatti RA: New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel SSCP strategy.Hum Mutat 14: 156–162, 1999

    PubMed  Google Scholar 

  31. Maillet P, Vaudan G, Chappuis P, Sappino A-P: PCR-mediated detection of a polymorphism in the ATM gene. Mol Cell Probes 13: 67–69, 1999

    PubMed  Google Scholar 

  32. Sandoval N, Platzer M, Rosenthal A, Dork T, Bendix R, Skawran B, Stuhrmann M, Wegner R-D, Sperling K, Banin S, Shiloh Y, Baumer A, Bernthlaler U, Sennefelder H, Brohm M, Weber BHF, Schindler D: Characterization of ATMgene mutations in 66 ataxia-telangiectasia families.Hum Mol Genet 8: 69–79, 1999

    PubMed  Google Scholar 

  33. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL: M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet 11: 447–449, 1995

    PubMed  Google Scholar 

  34. Maslen C, Babcock D, Raghunath M, Steinmann B: A rare branch-point mutation is associated with missplicing of fibrillin-Z in a large family with congenital contractural arachnodactyly.Am J Hum Genet 60: 1389–1398, 1997

    PubMed  Google Scholar 

  35. Tsai T, Davalath S, Rankin C, Radich JP, Head D, Appelbaum FR, Boldt DH: Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies. Leukemia 10: 1901–1910, 1996

    PubMed  Google Scholar 

  36. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium.Proc NatI Acad Sci USA 94: 10895–10900, 1997

    Google Scholar 

  37. Peral B, Gamble V, Strong C, Ong ACM, Sloane-Stanley J, Zerres K, Winearls CG, Harris PC: Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach. Am J Hum Genet 60: 1399– 1410, 1997

    Google Scholar 

  38. Ritis K, Steletas M, Tsiroxidoe V, Pardali E, Kanariol M, Moschese V, Orlandi P,SkordalaM, Rossi P, Kartalis G, Bourikas G, Sideras P: Absence of Bruton's tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia.Br J Haematol 102: 1241–1248, 1998

    PubMed  Google Scholar 

  39. Toyoshima M, Hara T, Zhang H, Yamamoto T, Akaboshi S, Nanba E, Ohno K, Hori N, Sato K, Takeshita K: Ataxiatelangiectasia without immunodeficiency: novel point mutations within and adjacent to the phosphatidylinositol 3-kinaselike domain. Am J Med Genet 75: 141–144, 1998

    PubMed  Google Scholar 

  40. Macera MJ, Godec CJ, Sharma N, Verma RS: Loss of heterozygosity of the TP53 tumor suppressor gene and detection of point mutations by the non-isotopic RNAse cleavage assay in prostate cancer.Cancer Genet Cytogenet 108: 42–47, 1999

    PubMed  Google Scholar 

Download references

Authors
  1. Karen C. Drumea
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eva Levine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jonine Bernstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Brenda Shank
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sheryl Green
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Edward Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lynda Mandell
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Joan Cropley
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Juliette Obropta
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Irene Braccia
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Amy Krupnik
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Barry S. Rosenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drumea, K.C., Levine, E., Bernstein, J. et al. ATM heterozygosity and breast cancer: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay. Breast Cancer Res Treat 61, 79–85 (2000). https://doi.org/10.1023/A:1006463730337

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006463730337

Search

Navigation